Large independent prospective study to evaluate the performance of ThyroSeq V.2 multigene next-generation sequencing panel analysis on cancer diagnosis in thyroid nodules with indeterminate cytology
have limited independent validation in clinical practice. Objective: To evaluate the performance of ThyroSeq V.2 to predict malignancy in 745 sequential FNABs with a Bethesda III, IV and V classification ... were…

